Skin barrier damage and itch
Gil Yosipovitch, Laurent Misery, Ehrhardt Proksch, Martin Metz, Sonja Ständer, Martin Schmelz
A summary of research and current opinion on available topical therapies for itch and recommendations for the optimal management.
Patient-reported outcomes in psoriasis
Nikolai Dyrberg Loft, Alexander Egeberg, Mads Kirchheiner Rasmussen, Lars Erik Bryld, Robert Gniadecki, Tomas Norman Dam, Lars Iversen, Lone Skov
Measuring and monitoring of patients' symptoms are important, and additional measures to capture symptoms might be beneficial in daily practice.
Characteristics of mycosis fungoides and Sézary syndrome
Pia Rude Nielsen, Jens Ole Eriksen, Ulrike Wehkamp, Lise Maria Lindahl, Robert Gniadecki, Hanne Fogh, Susanne Fabricius, Michael Bzorek, Niels Ødum, Lise Mette Rahbek Gjerdrum
This study describes all aspects of clinical and histopathological findings in patients with mycosis fungoides and Sézary syndrome in a well-characterized Danish cohort.
Botulinum toxin injections in axillary hyperhidrosis: a 15-year study
Clémence Berthin, Hervé Maillard
Repeated botulinum toxin A injections lead to an increase in duration of efficacy without secondary decrease.
Tumour volume doubling times – periocular and other BCCs
Andre Boo Shern Khoo, Patrick Kin Yoong Goon, Holger Sudhoff, Peter Kin Cho Goon
These new data can guide clinicians as to how much time there is available for removal or treatment before crucial parts of our anatomy could be affected.
Patch testing with isobornyl acrylate in contact dermatitis patients from insulin pumps
Martin Mowitz, Louise Fornander, Sara Hosseiny, Kristina Ryberg, Magnus Bruze
In this report the results from patch testing with isobornyl acrylate in 4 Swedish dermatology clinics is presented.
Atopic dermatitis-like eruption induced by biologics in psoriatic arthritis patient
Fumihito Abe, Shinji Mitsuyama, Eri Nagao, Masaaki Kimura, Tetsuya Higuchi
A patient with psoriatic arthritis who developed atopic dermatitis-like eruptions caused by the separate administration of 2 types of biologics, infliximab and ixekizumab, is described.
Possible paradoxical photosensitive psoriasis induced by TNF-alpha inhibi
Pauline Bataille, Adèle De Masson, Marie-Dominique Vignon-Pennamen, Jean-David Bouaziz, Jean-Marc Gornet
Un unusual case of sun-induced paradoxical psorisis in an adult patient treated with infliximab for Crohn's disease.